Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy)

Journal of the American College of Cardiology

Volumn 66, Issue 8, 2015, Pages 905-914

  McNamara, Dennis M ^a   Elkayam, Uri ^b   Alharethi, Rami ^c   Damp, Julie ^d   Hsich, Eileen ^e   Ewald, Gregory ^f   Modi, Kalgi ^g   Alexis, Jeffrey D ^h   Ramani, Gautam V ⁱ   Semigran, Marc J ^j   Haythe, Jennifer ^k   Markham, David W ^l   Marek, Josef ^a   Gorcsan, John ^a   Wu, Wen Chi ^m   Lin, Yan ^m   Halder, Indrani ^a   Pisarcik, Jessica ^a   Cooper, Leslie T ⁿ   Fett, James D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c INTERMOUNTAIN MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g LOUISIANA STATE UNIVERSITY   (United States)

^h UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

ⁱ UNIVERSITY OF MARYLAND   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k Och Spine at New York Presbyterian Hospitals   (United States)

^l EMORY UNIVERSITY   (United States)

^m UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ MAYO CLINIC   (United States)

more..

Author keywords

heart failure; myocardial recovery; race; remodeling

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; BLACK PERSON; CAUCASIAN; CLINICAL EVALUATION; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NORTH AMERICA; OUTCOME ASSESSMENT; PERIPARTUM CARDIOMYOPATHY; PRIORITY JOURNAL; RACE DIFFERENCE; ADOLESCENT; ANCESTRY GROUP; CARDIOMYOPATHIES; CLINICAL TRIAL; HEART STROKE VOLUME; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDY; PUERPERIUM; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOMYOPATHIES; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; STROKE VOLUME; UNITED STATES; YOUNG ADULT;

EID: 84939506158     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.06.1309     Document Type: Article

References (25)

1. U. Elkayam Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management J Am Coll Cardiol 58 2011 659 670
2. L.M. Mielniczuk, K. Williams, D.R. Davis, and et al. Frequency of peripartum cardiomyopathy Am J Cardiol 97 2006 1765 1768
3. J.D. Fett, L.G. Christie, R.D. Carraway, and et al. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution Mayo Clin Proc 80 2005 1602 1606
4. K. Sliwa, O. Förster, E. Libhaber, and et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients Eur Heart J 27 2006 441 446
5. S.S. Brar, S.S. Khan, G.K. Sandhu, and et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy Am J Cardiol 100 2007 302 304
6. M.A. Harper, R.E. Meyer, and C.J. Berg Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality Obstet Gynecol 120 2012 1013 1019
7. G.D. Pearson, J.C. Veille, S. Rahimtoola, and et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review JAMA 283 2000 1183 1188
8. N. Gleicher, and U. Elkayam Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev 8 2009 384 387
9. T.C. Pulerwitz, T.P. Cappola, G.M. Felker, and et al. Mortality in primary and secondary myocarditis Am Heart J 147 2004 746 750
10. A. Morales, T. Painter, R. Li, and et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy Circulation 121 2010 2176 2182
11. K.Y. van Spaendonck-Zwarts, J.P. van Tintelen, D.J. van Veldhuisen, and et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy Circulation 121 2010 2169 2175
12. I.S. Patten, S. Rana, S. Shahul, and et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy Nature 485 2012 333 338
13. S. Goland, K. Modi, F. Bitar, and et al. Clinical profile and predictors of complications in peripartum cardiomyopathy J Cardiac Fail 15 2009 645 650
14. C.W. Yancy, M. Jessup, B. Bozkurt, and et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
15. Authors/Task Force Members J.J. McMurray, S. Adamopoulos, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 Eur Heart J 33 2012 1787 1847
16. D.P. Kao, E. Hsich, and J. Lindenfeld Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy J Am Coll Cardiol HF 1 2013 409 416
17. D.M. McNamara, R.C. Starling, L.T. Cooper, et al. for the IMAC Investigators Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 Study J Am Coll Cardiol 58 2011 1112 1118
18. L.T. Cooper, P.J. Mather, J.D. Alexis, and et al. Myocardial recovery in peripartum cardiomyopathy; prospective comparison with recent onset cardiomyopathy in men and nonperipartum women J Card Fail 18 2012 28 33
19. J. Pillarisetti, A. Kondur, A. Alani, and et al. Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use J Am Coll Cardiol 63 2014 2831 2839
20. D. Hilfiker-Kleiner, K. Kaminski, E. Podewski, and et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy Cell 128 2007 589 600
21. K. Sliwa, L. Blauwet, K. Tibazarwa, and et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study Circulation 121 2010 1465 1473
22. A. Haghikia, E. Podewski, E. Libhaber, and et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy Basic Res Cardiol 108 2013 366
23. N.B. Mathur, and D. Dhingra Breastfeeding Indian J Pediatr 81 2014 143 149
24. J.G. Safirstein, A.S. Ro, S. Grandhi, and et al. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet Int J Cardiol 154 2012 27 31
25. K.Y. van Spaendonck-Zwarts, A. Posafalvi, M.P. van den Berg, and et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy Eur Heart J 35 2014 2165 2173